Institutional Ownership
Conduit Pharmaceuticals Inc
CUSIP 20678X114*W EXP 09/22/202CDTTWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boothbay Fund Management, LLC | 250.0K | $1.27M |
| 2 | Polar Asset Management Partners Inc. | 950.0K | $7.2K |
| 3 | Toronto Dominion Bank | 755.4K | $6.0K |
| 4 | Mmcap International Inc. Spc | 700.0K | $5.8K |
| 5 | Saba Capital Management, L.P. | 765.0K | $5.8K |
| 6 | Clear Street Group Inc. | 534.4K | $4.4K |
| 7 | Decagon Asset Management LLP | 400.0K | $3.3K |
| 8 | D. E. Shaw & Co., Inc. | 375.0K | $2.8K |
| 9 | Wolverine Asset Management LLC | 243.5K | $2.0K |
| 10 | Rivernorth Capital Management, LLC | 200.0K | $1.7K |